Cancer combo trial pulled before it began
NCT ID NCT05982522
First seen Apr 09, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study was designed to test a new drug called IN10018 combined with chemotherapy and an immunotherapy for people with advanced solid tumors, specifically non-small cell lung cancer, who had already tried other treatments. The goal was to see if the combination could shrink tumors or slow their growth. However, the trial was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.